Theseus Pharmaceuticals Inc

NASDAQ:THRX   3:59:51 PM EDT
7.50
+0.55 (+7.91%)
Earnings Announcements

Theseus Pharmaceuticals Announces Business Highlights And Reports First Quarter 2022 Financial Results

Published: 05/12/2022 11:17 GMT
Theseus Pharmaceuticals Inc (THRX) - Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2022 Financial Results.
Theseus Pharmaceuticals Inc - Cash Runway As of March 31 Expected to Fund Operations Into Second Half of 2024.
Theseus Pharmaceuticals Inc - Net Loss Was $10.5 Million for Q1 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.